# A Pilot Study to Assess the Safety, PK and PD of Insulin Injected Via MicronJet or Conventional Needle

> **NCT00602914** · EARLY_PHASE1 · COMPLETED · sponsor: **NanoPass Technologies Ltd** · enrollment: 23 (actual)

## Conditions studied

- Intradermal Injections

## Interventions

- **DEVICE:** MicronJet
- **DEVICE:** MicronJet

## Key facts

- **NCT ID:** NCT00602914
- **Lead sponsor:** NanoPass Technologies Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-12
- **Final completion:** 2009-07
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2013-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00602914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00602914, "A Pilot Study to Assess the Safety, PK and PD of Insulin Injected Via MicronJet or Conventional Needle". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00602914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*